VDR and cholangiocarcinoma: For CCA, overexpression of VDR has been linked to a better prognosis for CCA patients and 22-oxa-1,25-dihydroxyvitamin D3, one kind of 1α,25(OH)2D3 analog, has been shown to be able to repress CCA cell growth in vitro and in vivo26, 27.